Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists
Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists have?
Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists has 127 citations in the OpenAlex counts ScholarIQ stores.
When was Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists published?
Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists has 2021 year in the ScholarIQ index.
What is the open-access status of Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists?
Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists has bronze oa status in the ScholarIQ index.
What is the DOI of Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists?
The DOI for Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists is on the source record.
What is the PMID of Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists?
The PMID for Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists is on the source record.
What is the OpenAlex record for Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists?
The OpenAlex for Dapagliflozin in HFrEF Patients Treated With Mineralocorticoid Receptor Antagonists is on the source record.